The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valbenazine Market Research Report 2025
Synopsis
Valbenazine is used to treat adults with tardive dyskinesia (a movement disorder). This medicine is available only with your doctor's prescription.
Highlights
The global Valbenazine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Valbenazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Valbenazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Valbenazine include BOC Sciences, Toronto Research Chemicals, AbMole BioScience, TargetMol, Adooq Bioscience, Clearsynth, Taiclone, CSNpharm and MedKoo, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Valbenazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valbenazine.
The Valbenazine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Valbenazine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valbenazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BOC Sciences
Toronto Research Chemicals
AbMole BioScience
TargetMol
Adooq Bioscience
Clearsynth
Taiclone
CSNpharm
MedKoo
Neurocrine Biosciences
Vcare Pharmatech
Segment by Type
40mg Capsule
60mg Capsule
80mg Capsule
Segment by Application
Tardive Dyskinesia
Tourette Syndrome
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valbenazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valbenazine is used to treat adults with tardive dyskinesia (a movement disorder). This medicine is available only with your doctor's prescription.
Highlights
The global Valbenazine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Valbenazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Valbenazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Valbenazine include BOC Sciences, Toronto Research Chemicals, AbMole BioScience, TargetMol, Adooq Bioscience, Clearsynth, Taiclone, CSNpharm and MedKoo, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Valbenazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valbenazine.
The Valbenazine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Valbenazine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valbenazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BOC Sciences
Toronto Research Chemicals
AbMole BioScience
TargetMol
Adooq Bioscience
Clearsynth
Taiclone
CSNpharm
MedKoo
Neurocrine Biosciences
Vcare Pharmatech
Segment by Type
40mg Capsule
60mg Capsule
80mg Capsule
Segment by Application
Tardive Dyskinesia
Tourette Syndrome
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valbenazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valbenazine Market Overview
1.1 Product Overview and Scope of Valbenazine
1.2 Valbenazine Segment by Type
1.2.1 Global Valbenazine Market Value Comparison by Type (2023-2029)
1.2.2 40mg Capsule
1.2.3 60mg Capsule
1.2.4 80mg Capsule
1.3 Valbenazine Segment by Application
1.3.1 Global Valbenazine Market Value by Application: (2023-2029)
1.3.2 Tardive Dyskinesia
1.3.3 Tourette Syndrome
1.4 Global Valbenazine Market Size Estimates and Forecasts
1.4.1 Global Valbenazine Revenue 2018-2029
1.4.2 Global Valbenazine Sales 2018-2029
1.4.3 Global Valbenazine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Valbenazine Market Competition by Manufacturers
2.1 Global Valbenazine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Valbenazine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Valbenazine Average Price by Manufacturers (2018-2023)
2.4 Global Valbenazine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Valbenazine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valbenazine, Product Type & Application
2.7 Valbenazine Market Competitive Situation and Trends
2.7.1 Valbenazine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valbenazine Players Market Share by Revenue
2.7.3 Global Valbenazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valbenazine Retrospective Market Scenario by Region
3.1 Global Valbenazine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Valbenazine Global Valbenazine Sales by Region: 2018-2029
3.2.1 Global Valbenazine Sales by Region: 2018-2023
3.2.2 Global Valbenazine Sales by Region: 2024-2029
3.3 Global Valbenazine Global Valbenazine Revenue by Region: 2018-2029
3.3.1 Global Valbenazine Revenue by Region: 2018-2023
3.3.2 Global Valbenazine Revenue by Region: 2024-2029
3.4 North America Valbenazine Market Facts & Figures by Country
3.4.1 North America Valbenazine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Valbenazine Sales by Country (2018-2029)
3.4.3 North America Valbenazine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valbenazine Market Facts & Figures by Country
3.5.1 Europe Valbenazine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Valbenazine Sales by Country (2018-2029)
3.5.3 Europe Valbenazine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valbenazine Market Facts & Figures by Country
3.6.1 Asia Pacific Valbenazine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Valbenazine Sales by Country (2018-2029)
3.6.3 Asia Pacific Valbenazine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Valbenazine Market Facts & Figures by Country
3.7.1 Latin America Valbenazine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Valbenazine Sales by Country (2018-2029)
3.7.3 Latin America Valbenazine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Valbenazine Market Facts & Figures by Country
3.8.1 Middle East and Africa Valbenazine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Valbenazine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Valbenazine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valbenazine Sales by Type (2018-2029)
4.1.1 Global Valbenazine Sales by Type (2018-2023)
4.1.2 Global Valbenazine Sales by Type (2024-2029)
4.1.3 Global Valbenazine Sales Market Share by Type (2018-2029)
4.2 Global Valbenazine Revenue by Type (2018-2029)
4.2.1 Global Valbenazine Revenue by Type (2018-2023)
4.2.2 Global Valbenazine Revenue by Type (2024-2029)
4.2.3 Global Valbenazine Revenue Market Share by Type (2018-2029)
4.3 Global Valbenazine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Valbenazine Sales by Application (2018-2029)
5.1.1 Global Valbenazine Sales by Application (2018-2023)
5.1.2 Global Valbenazine Sales by Application (2024-2029)
5.1.3 Global Valbenazine Sales Market Share by Application (2018-2029)
5.2 Global Valbenazine Revenue by Application (2018-2029)
5.2.1 Global Valbenazine Revenue by Application (2018-2023)
5.2.2 Global Valbenazine Revenue by Application (2024-2029)
5.2.3 Global Valbenazine Revenue Market Share by Application (2018-2029)
5.3 Global Valbenazine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BOC Sciences
6.1.1 BOC Sciences Corporation Information
6.1.2 BOC Sciences Description and Business Overview
6.1.3 BOC Sciences Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BOC Sciences Valbenazine Product Portfolio
6.1.5 BOC Sciences Recent Developments/Updates
6.2 Toronto Research Chemicals
6.2.1 Toronto Research Chemicals Corporation Information
6.2.2 Toronto Research Chemicals Description and Business Overview
6.2.3 Toronto Research Chemicals Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Toronto Research Chemicals Valbenazine Product Portfolio
6.2.5 Toronto Research Chemicals Recent Developments/Updates
6.3 AbMole BioScience
6.3.1 AbMole BioScience Corporation Information
6.3.2 AbMole BioScience Description and Business Overview
6.3.3 AbMole BioScience Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AbMole BioScience Valbenazine Product Portfolio
6.3.5 AbMole BioScience Recent Developments/Updates
6.4 TargetMol
6.4.1 TargetMol Corporation Information
6.4.2 TargetMol Description and Business Overview
6.4.3 TargetMol Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 TargetMol Valbenazine Product Portfolio
6.4.5 TargetMol Recent Developments/Updates
6.5 Adooq Bioscience
6.5.1 Adooq Bioscience Corporation Information
6.5.2 Adooq Bioscience Description and Business Overview
6.5.3 Adooq Bioscience Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Adooq Bioscience Valbenazine Product Portfolio
6.5.5 Adooq Bioscience Recent Developments/Updates
6.6 Clearsynth
6.6.1 Clearsynth Corporation Information
6.6.2 Clearsynth Description and Business Overview
6.6.3 Clearsynth Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Clearsynth Valbenazine Product Portfolio
6.6.5 Clearsynth Recent Developments/Updates
6.7 Taiclone
6.6.1 Taiclone Corporation Information
6.6.2 Taiclone Description and Business Overview
6.6.3 Taiclone Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taiclone Valbenazine Product Portfolio
6.7.5 Taiclone Recent Developments/Updates
6.8 CSNpharm
6.8.1 CSNpharm Corporation Information
6.8.2 CSNpharm Description and Business Overview
6.8.3 CSNpharm Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CSNpharm Valbenazine Product Portfolio
6.8.5 CSNpharm Recent Developments/Updates
6.9 MedKoo
6.9.1 MedKoo Corporation Information
6.9.2 MedKoo Description and Business Overview
6.9.3 MedKoo Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 MedKoo Valbenazine Product Portfolio
6.9.5 MedKoo Recent Developments/Updates
6.10 Neurocrine Biosciences
6.10.1 Neurocrine Biosciences Corporation Information
6.10.2 Neurocrine Biosciences Description and Business Overview
6.10.3 Neurocrine Biosciences Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neurocrine Biosciences Valbenazine Product Portfolio
6.10.5 Neurocrine Biosciences Recent Developments/Updates
6.11 Vcare Pharmatech
6.11.1 Vcare Pharmatech Corporation Information
6.11.2 Vcare Pharmatech Valbenazine Description and Business Overview
6.11.3 Vcare Pharmatech Valbenazine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Vcare Pharmatech Valbenazine Product Portfolio
6.11.5 Vcare Pharmatech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valbenazine Industry Chain Analysis
7.2 Valbenazine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valbenazine Production Mode & Process
7.4 Valbenazine Sales and Marketing
7.4.1 Valbenazine Sales Channels
7.4.2 Valbenazine Distributors
7.5 Valbenazine Customers
8 Valbenazine Market Dynamics
8.1 Valbenazine Industry Trends
8.2 Valbenazine Market Drivers
8.3 Valbenazine Market Challenges
8.4 Valbenazine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Valbenazine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Valbenazine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Valbenazine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Valbenazine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Valbenazine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Valbenazine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Valbenazine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Valbenazine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Valbenazine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Valbenazine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valbenazine, Product Type & Application
Table 12. Global Key Manufacturers of Valbenazine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valbenazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valbenazine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valbenazine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Valbenazine Sales by Region (2018-2023) & (K Units)
Table 18. Global Valbenazine Sales Market Share by Region (2018-2023)
Table 19. Global Valbenazine Sales by Region (2024-2029) & (K Units)
Table 20. Global Valbenazine Sales Market Share by Region (2024-2029)
Table 21. Global Valbenazine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Valbenazine Revenue Market Share by Region (2018-2023)
Table 23. Global Valbenazine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Valbenazine Revenue Market Share by Region (2024-2029)
Table 25. North America Valbenazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Valbenazine Sales by Country (2018-2023) & (K Units)
Table 27. North America Valbenazine Sales by Country (2024-2029) & (K Units)
Table 28. North America Valbenazine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Valbenazine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Valbenazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Valbenazine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Valbenazine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Valbenazine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Valbenazine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Valbenazine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Valbenazine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Valbenazine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Valbenazine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Valbenazine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Valbenazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Valbenazine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Valbenazine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Valbenazine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Valbenazine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Valbenazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Valbenazine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Valbenazine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Valbenazine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Valbenazine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Valbenazine Sales (K Units) by Type (2018-2023)
Table 51. Global Valbenazine Sales (K Units) by Type (2024-2029)
Table 52. Global Valbenazine Sales Market Share by Type (2018-2023)
Table 53. Global Valbenazine Sales Market Share by Type (2024-2029)
Table 54. Global Valbenazine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Valbenazine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Valbenazine Revenue Market Share by Type (2018-2023)
Table 57. Global Valbenazine Revenue Market Share by Type (2024-2029)
Table 58. Global Valbenazine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Valbenazine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Valbenazine Sales (K Units) by Application (2018-2023)
Table 61. Global Valbenazine Sales (K Units) by Application (2024-2029)
Table 62. Global Valbenazine Sales Market Share by Application (2018-2023)
Table 63. Global Valbenazine Sales Market Share by Application (2024-2029)
Table 64. Global Valbenazine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Valbenazine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Valbenazine Revenue Market Share by Application (2018-2023)
Table 67. Global Valbenazine Revenue Market Share by Application (2024-2029)
Table 68. Global Valbenazine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Valbenazine Price (US$/Unit) by Application (2024-2029)
Table 70. BOC Sciences Corporation Information
Table 71. BOC Sciences Description and Business Overview
Table 72. BOC Sciences Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. BOC Sciences Valbenazine Product
Table 74. BOC Sciences Recent Developments/Updates
Table 75. Toronto Research Chemicals Corporation Information
Table 76. Toronto Research Chemicals Description and Business Overview
Table 77. Toronto Research Chemicals Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Toronto Research Chemicals Valbenazine Product
Table 79. Toronto Research Chemicals Recent Developments/Updates
Table 80. AbMole BioScience Corporation Information
Table 81. AbMole BioScience Description and Business Overview
Table 82. AbMole BioScience Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. AbMole BioScience Valbenazine Product
Table 84. AbMole BioScience Recent Developments/Updates
Table 85. TargetMol Corporation Information
Table 86. TargetMol Description and Business Overview
Table 87. TargetMol Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. TargetMol Valbenazine Product
Table 89. TargetMol Recent Developments/Updates
Table 90. Adooq Bioscience Corporation Information
Table 91. Adooq Bioscience Description and Business Overview
Table 92. Adooq Bioscience Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Adooq Bioscience Valbenazine Product
Table 94. Adooq Bioscience Recent Developments/Updates
Table 95. Clearsynth Corporation Information
Table 96. Clearsynth Description and Business Overview
Table 97. Clearsynth Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Clearsynth Valbenazine Product
Table 99. Clearsynth Recent Developments/Updates
Table 100. Taiclone Corporation Information
Table 101. Taiclone Description and Business Overview
Table 102. Taiclone Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Taiclone Valbenazine Product
Table 104. Taiclone Recent Developments/Updates
Table 105. CSNpharm Corporation Information
Table 106. CSNpharm Description and Business Overview
Table 107. CSNpharm Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CSNpharm Valbenazine Product
Table 109. CSNpharm Recent Developments/Updates
Table 110. MedKoo Corporation Information
Table 111. MedKoo Description and Business Overview
Table 112. MedKoo Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. MedKoo Valbenazine Product
Table 114. MedKoo Recent Developments/Updates
Table 115. Neurocrine Biosciences Corporation Information
Table 116. Neurocrine Biosciences Description and Business Overview
Table 117. Neurocrine Biosciences Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Neurocrine Biosciences Valbenazine Product
Table 119. Neurocrine Biosciences Recent Developments/Updates
Table 120. Vcare Pharmatech Corporation Information
Table 121. Vcare Pharmatech Description and Business Overview
Table 122. Vcare Pharmatech Valbenazine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Vcare Pharmatech Valbenazine Product
Table 124. Vcare Pharmatech Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Valbenazine Distributors List
Table 128. Valbenazine Customers List
Table 129. Valbenazine Market Trends
Table 130. Valbenazine Market Drivers
Table 131. Valbenazine Market Challenges
Table 132. Valbenazine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valbenazine
Figure 2. Global Valbenazine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Valbenazine Market Share by Type in 2022 & 2029
Figure 4. 40mg Capsule Product Picture
Figure 5. 60mg Capsule Product Picture
Figure 6. 80mg Capsule Product Picture
Figure 7. Global Valbenazine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Valbenazine Market Share by Application in 2022 & 2029
Figure 9. Tardive Dyskinesia
Figure 10. Tourette Syndrome
Figure 11. Global Valbenazine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Valbenazine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Valbenazine Sales (2018-2029) & (K Units)
Figure 14. Global Valbenazine Average Price (US$/Unit) & (2018-2029)
Figure 15. Valbenazine Report Years Considered
Figure 16. Valbenazine Sales Share by Manufacturers in 2022
Figure 17. Global Valbenazine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Valbenazine Players: Market Share by Revenue in 2022
Figure 19. Valbenazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Valbenazine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Valbenazine Sales Market Share by Country (2018-2029)
Figure 22. North America Valbenazine Revenue Market Share by Country (2018-2029)
Figure 23. United States Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Valbenazine Sales Market Share by Country (2018-2029)
Figure 26. Europe Valbenazine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Valbenazine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Valbenazine Revenue Market Share by Region (2018-2029)
Figure 34. China Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Valbenazine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Valbenazine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Colombia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Valbenazine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Valbenazine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Valbenazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Valbenazine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Valbenazine by Type (2018-2029)
Figure 56. Global Valbenazine Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Valbenazine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Valbenazine by Application (2018-2029)
Figure 59. Global Valbenazine Price (US$/Unit) by Application (2018-2029)
Figure 60. Valbenazine Value Chain
Figure 61. Valbenazine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
